HEALIUS LIMITED — Director's Dealing 2014

Oct 26, 2014

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity	PRIMARY HEALTH CARE LIMITED
ABN	24 064 530 516

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Dr Edmund Gregory Thomas Bateman
Date of last notice	15 October 2014

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	In respect of Mrs Belinda Bateman’s holding
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.	Not applicable
Date of change	24 October 2014
No. of securities held prior to change	406,483 Abtourk (Syd No.391) Pty Ltd 17,413,251 Idameneo (No. 122) Pty Ltd 104,836 Belinda Carwardine Bateman and Edmund Gregory Thomas Bateman 150,000 Belinda Carwardine Bateman 756,258 Dr Edmund Bateman 18,830,828 Ordinary shares
Class	Fully paid ordinary shares
Number acquired	Not applicable
Number disposed	20,000
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation	$4.49 per share

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

No. of securities held after change	406,483 Abtourk (Syd No.391) Pty Ltd 17,413,251 Idameneo (No. 122) Pty Ltd 104,836 Belinda Carwardine Bateman and Edmund Gregory Thomas Bateman 130,000 Belinda Carwardine Bateman 756,258 Dr Edmund Bateman 18,810,828 Ordinary shares
Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy- back	On-market trade

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	Not applicable
Nature of interest	Not applicable
Name of registered holder (if issued securities)	Not applicable
Date of change	Not applicable
No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed	Not applicable
Interest acquired	Not applicable
Interest disposed	Not applicable
Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation	Not applicable
Interest after change	Not applicable

Part 3 –[+] Closed period

Were the interests in the securities or contracts detailed above traded during a+closed period where **prior written clearance was required? **	Not applicable
If so, was prior written clearance provided to allow the trade to proceed during this period?	Not applicable
If prior written clearance was provided, on what date was this provided?	Not applicable

YD CACHIA Company Secretary Date: 27 October 2014

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011